Unexpected loss of contact allergy to aluminium induced by vaccine

Contact Dermatitis. 2013 May;68(5):286-92. doi: 10.1111/cod.12053.

Abstract

Background: In studies in Gothenburg, Sweden, in the 1990s of an aluminium hydroxide-adsorbed pertussis toxoid vaccine, 745 of ~76 000 vaccinated children developed long-lasting itchy subcutaneous nodules at the vaccination site. Of 495 children with itchy nodules patch tested for aluminium allergy, 376 (76%) were positive.

Objectives: To study the prognosis of the vaccine-induced aluminium allergy.

Patients and methods: Two hundred and forty-one children with demonstrated aluminium allergy in the previous study were patch tested again 5-9 years after the initial test, with the same procedure as used previously.

Results: Contact allergy to aluminium was no longer demonstrable in 186 of the retested 241 children (77%). A negative test result was more common in children who no longer had itching at the vaccination site; it was also related to the age of the child, the time after the first aluminium-adsorbed vaccine dose, and the strength of the reaction in the first test.

Conclusions: Patch test reactivity to aluminium seems to disappear or weaken with time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adolescent
  • Aluminum Compounds / administration & dosage*
  • Child
  • Dermatitis, Allergic Contact / immunology*
  • Dermatitis, Allergic Contact / prevention & control*
  • Desensitization, Immunologic
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / administration & dosage
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / immunology*
  • Dose-Response Relationship, Immunologic
  • Female
  • Humans
  • Male
  • Patch Tests
  • Prognosis
  • Time Factors

Substances

  • Adjuvants, Immunologic
  • Aluminum Compounds
  • Diphtheria-Tetanus-acellular Pertussis Vaccines